Skip to main content
TipRanks
Go Ultimate75% OFF

Aino Health AB (AINO) AI Stock Analysis

0 Followers
SE:AINO

Aino Health AB

(Nasdaq OMX AB:AINO)

Select Model
Rating:41Neutral
Price Target:SEK 0.17â–¼(-1.70% Downside)
Action:reiterated
Date:11/18/26

The overall score of 41 reflects a high-risk, distressed company. The most significant factors are the dire financial state, marked by insolvency, deep unprofitability, and severe cash burn. This is compounded by a bearish technical trend and a valuation that signals no fundamental support. The company's viability is a primary concern.

Positive Factors
Digital health business modelAino operates in a defined digital health and corporate health-management niche, addressing employer absenteeism and work ability through software, services, data-driven processes, and reporting. This gives the company a clear business use case for organizational customers over the medium term.
Negative Factors
Negative equity and thin capital baseNegative equity and debt exceeding total assets leave Aino with very limited financial flexibility. This weak capital structure increases refinancing and funding risk, and may constrain the company’s ability to absorb continued losses or invest in growth.

Aino Health AB (AINO) vs. iShares MSCI Sweden ETF (EWD)

-40%-20%0%20%40%60%SE:AINO+0.57%EWD+8.63%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SEK 36.00M
Dividend Yield
―
Average Volume (3M)
85.10K
Price to Earnings (P/E)
-3.4
Beta (1Y)
1.18
Revenue Growth
-10.72%
EPS Growth
-77.78%
Country
Sweden
Employees
18
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Aino Health AB Business Overview & Revenue Model

Company Description

Aino Health AB (publ), a Swedish company based in Stockholm, specializes in delivering comprehensive corporate health management solutions to both private and public organizations throughout Finland. Their flagship offering is HealthManager, a Softwa...

How the Company Makes Money

Aino Health AB primarily makes money by selling its digital health/absence-management solution and related services to business customers (employers/organizations). Revenue is generated through customer contracts for access to the company’s platform...

Aino Health AB Financial Statement Overview

Summary

Financial health is critically weak. The company is deeply unprofitable with a TTM net loss margin of -41.6%, is technically insolvent with negative equity of -11.3 million, and is burning cash with TTM operating cash flow of -6.0 million. The only positive is an improved gross margin, but it is overshadowed by severe operational and balance sheet distress.

Income Statement

8Very Negative

Balance Sheet

1Very Negative

Cash Flow

10Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue23.50M26.11M23.94M23.92M19.91M23.04M
Gross Profit6.04M-4.27M21.51M3.80M17.77M21.56M
EBITDA-6.01M-3.29M-6.21M-6.57M-11.29M-11.12M
Net Income-9.79M-6.11M-9.91M-10.66M-14.96M-15.22M
Balance Sheet
Total Assets4.87M9.70M9.86M13.51M17.33M19.02M
Cash, Cash Equivalents and Short-Term Investments1.92M5.81M741.00K1.44M2.16M453.00K
Total Debt7.98M8.32M170.00K164.00K659.00K1.06M
Total Liabilities16.20M16.12M10.32M14.37M19.57M16.44M
Stockholders Equity-11.33M-6.42M-458.00K-851.00K-2.23M2.58M
Cash Flow
Free Cash Flow-6.04M-2.41M-4.55M-6.26M-12.87M-8.11M
Operating Cash Flow-6.04M-2.41M-4.55M-6.26M-12.87M-8.11M
Investing Cash Flow00001.32M0
Financing Cash Flow7.21M7.62M3.82M5.57M13.19M-450.00K

Aino Health AB Technical Analysis

Technical Analysis SentimentNegative
Last Price0.18

Price Trends

50DMA0.19Negative
100DMA0.20Negative
200DMA0.17Positive

Market Momentum

MACD-0.00Positive
RSI41.62Neutral
STOCH32.14Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:AINO, the sentiment is Negative. The current price of 0.18 is below the 20-day moving average (MA) of 0.19, below the 50-day MA of 0.19, and above the 200-day MA of 0.17, indicating a neutral trend. The MACD of -0.00 indicates Positive momentum. The RSI at 41.62 is Neutral, neither overbought nor oversold. The STOCH value of 32.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:AINO.

Aino Health AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

SE:AINO against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:SUSSE:SUS73OutperformSEK 3.04B28.40――4.52%53.01%
SE:PTRKSE:PTRK59NeutralSEK 171.55M-1.95――-10.30%-11.59%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SE:KONTSE:KONT47NeutralSEK 45.12M-42.41-1.94%―0.97%41.35%
SE:AINOSE:AINO41NeutralSEK 36.00M-3.44105.04%―-10.72%-77.78%
SE:QLINEASE:QLINEA41NeutralSEK 215.07M-1.31-48.10%―33.26%90.73%

* Healthcare Sector Average

Performance Comparison

-50%-25%0%25%SE:AINOSE:QLINEASE:KONTSE:SUSSE:PTRKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SE:AINO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SE:AINOAino Health AB0.18-0.03-15.38%
SE:QLINEAQ-linea AB11.15-13.80-55.31%
SE:KONTKontigo Care AB1.19-0.86-42.20%
SE:SUSSurgical Science Sweden AB60.25-12.95-17.69%
SE:PTRKPhysitrack Limited10.55-4.35-29.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 18, 2026